Associate Director, Clinical Pharmacology and Pharmacometrics at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Advanced Degree in related field (MS, Ph.D. or PharmD)
  • For Associate Director with Ph.D., approximately 5+ years of experience with demonstrated progression in clinical pharmacology and pharmacometrics; for M.S. Degree, 10 years of experience with demonstrated progression in clinical pharmacology and pharmacometrics
  • Demonstrated ability to work in a dynamic team-oriented environment
  • Experience leading a Clinical Pharmacology team is required for the Director level position
  • Expertise in general drug development
  • Expertise in small molecule and/or biologic drug property characterization
  • Demonstrated stakeholder management with strong influence/leadership
  • Hands on and demonstrated Pharmacometrics experience required including exposure-response modeling
  • Quantitative data analysis, POP PK/PD, and data visualization skills
  • Programming experience (e.g., NONMEM, Phoenix NLME, Monolix, R, WinNonlin, SAS, Splus etc.)
  • Ability to work hybrid work hours in office 50% of the time per week located in Princeton BMS office

Responsibilities

  • Independently contribute to compound development across various development phases
  • Represent Clin Pharm on asset teams and at governance meetings based on proficiency
  • Provide input to Phase 2/3 clinical study design and registrational strategy
  • Accountable for the Clinical Pharmacology Plan
  • Lead design of clinical pharmacology studies and manages data analysis, interpretation, and reporting
  • High proficiency in PK, PK/PD, and model informed drug development (MIDD) principles and analyses
  • Collaborate on cross-functional drug development teams, and regulatory submissions; serves as Clinical Pharmacology subject matter expert

Skills

Clinical Pharmacology
Pharmacometrics
Pharmacokinetics
Exposure-Response Analysis
Quantitative Systems Pharmacology
PBPK Modeling
Model-Based Meta-Analysis
Data Science
Modeling

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI